Last 12 months
Inside the activity.
4 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2022 Filed Feb 28, 2022 21:05 UTC |
Kelly Timothy PChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-008062 · doc4.xml · derivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 4,800 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:05 UTC |
Kelly Timothy PChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 28,200 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0000899243-22-008062 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,200 Underlying: Common Stock · 28,200 shares Expires 2032-02-24 F1 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:05 UTC |
Seymour AlbertChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-008060 · doc4.xml · derivative · entry 2 Seymour Albert · CIK 0001735324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:05 UTC |
Seymour AlbertChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 128,000 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0000899243-22-008060 · doc4.xml · derivative · entry 1 Seymour Albert · CIK 0001735324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,000 Underlying: Common Stock · 128,000 shares Expires 2032-02-24 F1 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022. Read SEC document |
| January 05, 2022 Filed Jan 12, 2022 21:05 UTC |
Smith W BradfordCFO & Treasurer
|
SaleCommon Stock | 2,182 | $3.78 | $8,248.40 |
DisclosureSEC source: 0000899243-22-001749 · doc4.xml · nonDerivative · entry 2 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,418 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.80. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| January 05, 2022 Filed Jan 12, 2022 21:05 UTC |
TZIANABOS ARTHURDirector · President & CEO
|
SaleCommon Stock | 5,354 | $3.78 | $20,239.19 |
DisclosureSEC source: 0000899243-22-001743 · doc4.xml · nonDerivative · entry 2 TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,011 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.80. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| January 05, 2022 Filed Jan 12, 2022 21:05 UTC |
Kelly Timothy PChief Operating Officer
|
SaleCommon Stock | 1,406 | $3.78 | $5,314.82 |
DisclosureSEC source: 0000899243-22-001747 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,224 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| January 05, 2022 Filed Jan 12, 2022 21:05 UTC |
Seymour AlbertChief Scientific Officer
|
SaleCommon Stock | 1,661 | $3.78 | $6,278.75 |
DisclosureSEC source: 0000899243-22-001746 · doc4.xml · nonDerivative · entry 2 Seymour Albert · CIK 0001735324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,646 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| January 05, 2022 Filed Jan 12, 2022 21:05 UTC |
Cohn GabrielChief Medical Officer
|
SaleCommon Stock | 1,661 | $3.78 | $6,278.75 |
DisclosureSEC source: 0000899243-22-001745 · doc4.xml · nonDerivative · entry 2 Cohn Gabriel · CIK 0001794702 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,629 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Smith W BradfordCFO & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001749 · doc4.xml · derivative · entry 3 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,400 Underlying: Common Stock · 6,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Smith W BradfordCFO & Treasurer
|
Exercise / conversionCommon Stock | 6,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-001749 · doc4.xml · nonDerivative · entry 1 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
TZIANABOS ARTHURDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 13,860 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001743 · doc4.xml · derivative · entry 3 TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,140 Underlying: Common Stock · 13,860 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
TZIANABOS ARTHURDirector · President & CEO
|
Exercise / conversionCommon Stock | 13,860 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-001743 · doc4.xml · nonDerivative · entry 1 TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Kelly Timothy PChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,630 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001747 · doc4.xml · derivative · entry 3 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,370 Underlying: Common Stock · 3,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Kelly Timothy PChief Operating Officer
|
Exercise / conversionCommon Stock | 3,630 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-001747 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Seymour AlbertChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001746 · doc4.xml · derivative · entry 3 Seymour Albert · CIK 0001735324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,710 Underlying: Common Stock · 4,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Seymour AlbertChief Scientific Officer
|
Exercise / conversionCommon Stock | 4,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-001746 · doc4.xml · nonDerivative · entry 1 Seymour Albert · CIK 0001735324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Cohn GabrielChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001745 · doc4.xml · derivative · entry 3 Cohn Gabriel · CIK 0001794702 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,710 Underlying: Common Stock · 4,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2022 Filed Jan 12, 2022 21:05 UTC |
Cohn GabrielChief Medical Officer
|
Exercise / conversionCommon Stock | 4,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-001745 · doc4.xml · nonDerivative · entry 1 Cohn Gabriel · CIK 0001794702 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| September 03, 2021 Filed Sep 8, 2021 20:10 UTC |
Kelly Timothy PSee Remarks.
|
SaleCommon Stock | 54 | $7.70 | $415.80 |
DisclosureSEC source: 0000899243-21-035330 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · shares: Includes 54 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2021. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:39 UTC |
Poulton Jeffrey V.Director
|
GrantOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0000899243-21-025330 · doc4.xml · derivative · entry 1 Poulton Jeffrey V. · CIK 0001782962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 17:40 UTC |
Patterson Matthew RDirector
|
GrantOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0000899243-21-025333 · doc4.xml · derivative · entry 1 Patterson Matthew R · CIK 0001401018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:35 UTC |
GILLIS STEVENDirector
|
GrantOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0000899243-21-025321 · doc4.xml · derivative · entry 1 GILLIS STEVEN · CIK 0001229592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:35 UTC |
Thistle MaryDirector
|
GrantOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0000899243-21-025322 · doc4.xml · derivative · entry 1 Thistle Mary · CIK 0001317917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 17:41 UTC |
Gregory Richard J.Director
|
GrantOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0000899243-21-025335 · doc4.xml · derivative · entry 1 Gregory Richard J. · CIK 0001629767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:40 UTC |
PARMAR KUSHDirector
|
GrantOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0000899243-21-025334 · doc4.xml · derivative · entry 1 PARMAR KUSH · CIK 0001664281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:40 UTC |
REICIN ALISEDirector
|
GrantOption (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0000899243-21-025331 · doc4.xml · derivative · entry 1 REICIN ALISE · CIK 0001757533 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date. Read SEC document |
| April 07, 2021 Filed Apr 10, 2021 01:30 UTC |
Kelly Timothy PChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0000899243-21-015515 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-04-07 F1 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after April 12, 2021, so that such option will become fully vested on April 12, 2025. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC |
Kelly Timothy PSee Remarks.
|
Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · derivative · entry 5 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,001 Underlying: Common Stock · 2,000 shares Expires 2027-09-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was May 30, 2017. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC |
Kelly Timothy PSee Remarks.
|
Exercise / conversionEmployee Stock Options · Derivative | 2,000 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · derivative · entry 4 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 2,000 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC |
Kelly Timothy PSee Remarks.
|
SaleCommon Stock | 6,232 | $11.16 | $69,562.83 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 3 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.9600 to $11.3100. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC |
Kelly Timothy PSee Remarks.
|
Exercise / conversionCommon Stock | 2,000 | $2.89 | $5,789.40 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:05 UTC |
Kelly Timothy PSee Remarks.
|
Exercise / conversionCommon Stock | 2,000 | $6.63 | $13,262.80 |
DisclosureSEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,232 shares acquired under Issuer's Employee Stock Purchase Plan on February 26, 2021. Read SEC document |
| March 01, 2021 Filed Sep 8, 2021 20:05 UTC Amendment |
Kelly Timothy PSee Remarks
|
SaleCommon Stock | 6,232 | $11.16 | $69,562.83 |
DisclosureSEC source: 0000899243-21-035329 · doc4a.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.9600 to $11.3100. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:22 UTC |
Smith W BradfordCFO & Treasurer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 13,500 | $0.00 Strike: $0.64 | $0.00 |
DisclosureSEC source: 0000899243-21-005458 · doc4.xml · derivative · entry 5 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,904 Underlying: Common Stock · 13,500 shares Expires 2027-04-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:22 UTC |
Smith W BradfordCFO & Treasurer
|
SaleCommon Stock | 13,500 | $14.25 | $192,424.95 |
DisclosureSEC source: 0000899243-21-005458 · doc4.xml · nonDerivative · entry 2 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $14.00 to $14.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:22 UTC |
Smith W BradfordCFO & Treasurer
|
Exercise / conversionCommon Stock | 13,500 | $0.64 | $8,640.00 |
DisclosureSEC source: 0000899243-21-005458 · doc4.xml · nonDerivative · entry 1 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:22 UTC |
Smith W BradfordCFO & Treasurer
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005458 · doc4.xml · derivative · entry 4 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F5 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. F5 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:22 UTC |
Smith W BradfordCFO & Treasurer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 122,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0000899243-21-005458 · doc4.xml · derivative · entry 3 Smith W Bradford · CIK 0001317678 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,000 Underlying: Common Stock · 122,000 shares Expires 2031-02-05 F3 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:21 UTC |
TZIANABOS ARTHURDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 42,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005455 · doc4.xml · derivative · entry 2 TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:21 UTC |
TZIANABOS ARTHURDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 254,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0000899243-21-005455 · doc4.xml · derivative · entry 1 TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,000 Underlying: Common Stock · 254,000 shares Expires 2031-02-05 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:25 UTC |
Seymour AlbertChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005461 · doc4.xml · derivative · entry 2 Seymour Albert · CIK 0001735324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:25 UTC |
Seymour AlbertChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 78,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0000899243-21-005461 · doc4.xml · derivative · entry 1 Seymour Albert · CIK 0001735324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Common Stock · 78,000 shares Expires 2031-02-05 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:22 UTC |
Cohn GabrielChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005456 · doc4.xml · derivative · entry 2 Cohn Gabriel · CIK 0001794702 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:22 UTC |
Cohn GabrielChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 78,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0000899243-21-005456 · doc4.xml · derivative · entry 1 Cohn Gabriel · CIK 0001794702 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Common Stock · 78,000 shares Expires 2031-02-05 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:24 UTC |
Kelly Timothy PSee Remarks
|
GrantRestricted Stock Units · Derivative | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-005460 · doc4.xml · derivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 21:24 UTC |
Kelly Timothy PSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $13.78 | $0.00 |
DisclosureSEC source: 0000899243-21-005460 · doc4.xml · derivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2031-02-05 F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 11:31 UTC |
Kelly Timothy PSee Remarks
|
Exercise / conversionEmployee Stock Options · Derivative | 500 | $0.00 Strike: $6.63 | $0.00 |
DisclosureSEC source: 0000899243-21-004998 · doc4.xml · derivative · entry 3 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 500 shares Expires 2027-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 11:31 UTC |
Kelly Timothy PSee Remarks
|
SaleCommon Stock | 500 | $13.00 | $6,500.00 |
DisclosureSEC source: 0000899243-21-004998 · doc4.xml · nonDerivative · entry 2 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 11:31 UTC |
Kelly Timothy PSee Remarks
|
Exercise / conversionCommon Stock | 500 | $6.63 | $3,315.70 |
DisclosureSEC source: 0000899243-21-004998 · doc4.xml · nonDerivative · entry 1 Kelly Timothy P · CIK 0001754067 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.